Identifying the Role of Clinical Biomarkers in Genome Editing Therapeutics for Sickle Cell Disease
Time: 3:00 pm
day: Day Two
Details:
- Biomarkers to support efficacy of gene editing therapies to treat sickle cell disease
- Specialized biomarker discovery to assess disease pathophysiology
- Importance and opportunity biomarkers bring to accelerate clinical development